McKesson Corporation Drugs, proprietaries, & sundries

Stock predictor AI models:
$ 140.94 Last close price
at 09-jul-2020

MCK

Model's trade recommendations No return for period yet

$31.91B Market Cap

β 1.31  

MCK

Model (following trade recommendations)

MCK

Underlying stock

S&P 500

Index
Return for period
-3.83%
1.78%
52wk return
-2.00%
16.82%
52wk Range
115.75—170.96
2000.54—2399.63
  • 1.36 (0.88%) Div (Yield)
  • BUY Analysts consensus recommendation

McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by their ICARE shared principles, their employees work every day to innovate and deliver opportunities that make their customers and partners more successful - all for the better health of patients.

Industry sector: Medical

Sector classification: Drugs, proprietaries, & sundries

-->
Float 204M
P/E 12.33
Shares Outstanding 206M
% Held by Insiders 1.20%
% Held by Institutions 88.62%
EPS (last reported FY) $11.61
EPS (last reported Q) $3.41
EPS, estimated (last reported Q) $2.92
Total revenues $199 B
Net income $5 B